Quantification of the usage of symptomatic treatment in patients suffering from multiple sclerosis.
<p><strong>Background:</strong> Multiple sclerosis is a chronic demyelinated disease which constitutes de first cause of neurological handicaps in young adult patients and has no curative treatment. There are other options in which treatment of great importance can be applied for e...
Saved in:
Main Authors: | Erélido Hernández Valero, Mikhail Benet Rodríguez |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2007-08-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/266 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse Reactions due to the Usage Ofadverse Effects due to the Usage of T biomodulina and corticotropin in Patients Suffering from Multiple Sclerosis
by: Rosa F. Lara Rodríguez, et al.
Published: (2007-05-01) -
Effectiveness of comprehensive neurorehabilitation treatment on the cognitive function of patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-05-01) -
Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01) -
Health-related quality of life in patients with multiple sclerosis
by: Lázaro Aurelio Vázquez Gómez, et al.
Published: (2022-02-01) -
Epidemiological, clinical and imaging profile of Multiple Sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2021-12-01)